Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts

作者：Xu Wen Xiao; Liu Sheng Zhi; Wu Di; Qiao Guo Fen; Yan Jinglong^*

来源：Cellular Physiology and Biochemistry, 2015, 37(4): 1581-1591.

DOI：10.1159/000438525

• Promyelocytic leukemia
• Sumoylation
• Osteoblasts
• Collagen synthesis
• Arsenic trioxide
• RNF4
• UBC9

Background/Aims: Promyelocytic leukemia (PML) protein is a tumor suppressor that fuses with retinoic acid receptor-a (PML-RARa) to contribute to the initiation of acute promyelocytic leukemia (APL). Arsenic trioxide (ATO) upregulates expression of TGF-beta 1, promoting collagen synthesis in osteoblasts, and ATO binds directly to PML to induce oligomerization, sumoylation, and ubiquitination. However, how ATO upregulates TGF-beta 1 expression is uncertain. Thus, we suggested that PML sumoylation is responsible for regulation of TGF-beta 1 protein expression. Methods: Kunming mice were treated with ATO, and osteoblasts were counted under scanning electron microscopy. Masson's staining was used to quantify collagen content. hFOB1.19 cells were transfected with siRNA against UBC9 or RNF4, and then treated with ATO or FBS. TGF-beta 1, PML expression, and sumoylation were quantified with Western blot, and collagen quantified via immunocytochemistry. Results: ATO enhanced osteoblast accumulation, collagen synthesis, and PML-NB formation in vivo. Knocking down UBC9 in hFOB1.19 cells inhibited ATO- and FBS-induced PML sumoylation, TGF-beta 1 expression, and collagen synthesis. Conversely, knocking down RNF4 enhanced ATO- and FBS-induced PML sumoylation, TGF-beta 1 expression, and collagen synthesis. Conclusion: These data suggest that PML sumoylation is required for ATO-induced collagen synthesis in osteoblasts.

• 出版日期2015
• 单位哈尔滨医科大学